Charoen Pokphand Foods Public Company Limited (CP Foods) reported a record-breaking performance in the first quarter of 2025, with a net profit of THB 8.549 billion—an increase of 642% or six times higher than the same period last year. The surge reflects CP Foods’ strong adaptability to economic and geopolitical challenges, along with its strict disease prevention systems and high occupational health and safety standards implemented throughout its operations.

Prasit Boondoungprasert, Chief Executive Officer of CP Foods, attributed the impressive Q1 2025 results to efficiency improvements and cost reductions throughout the entire supply chain. Furthermore, outbreaks of avian influenza in several countries, along with the ongoing impact of African Swine Fever (ASF), have led to a decrease in global poultry and swine supplies. Meanwhile, raw material costs have remained at favorable levels. These factors have enabled CP Foods to surpass its performance targets both domestically and in over 10 countries where it operates.

The company’s strong performance in Q1 2025 is a testament to the dedication of its global workforce and its long-term resilience across diverse environments. CP Foods’ continuous investments in innovation, technology, and the implementation of IT management systems—alongside its commitment to biosecurity and systematic disease prevention in livestock farming—are essential in strengthening the organization throughout the supply chain. These factors enable the company to maintain production stability and ensure consistent product quality.

Mr. Prasit further emphasized that CP Foods’ overall performance for 2025 is expected to surpass that of the previous year. This optimistic outlook is driven by the company’s ongoing strategic initiatives and a rebound in the industry from past challenges. Regarding concerns surrounding U.S. tariff policies, CP Foods remains unaffected due to its focus on affordable food products that are produced locally in over 10 countries. The company depends on exports only 4–5% of its sales, primarily to Asian markets such as Japan and European countries, with exports to the U.S. market accounting for just 0.3%.

Amid global animal disease outbreaks and the reemergence of COVID-19, CP Foods’ leadership has reinforced comprehensive risk management, targeted investments in promising sectors, and, most critically, elevated safety standards throughout its operations. This includes robust disease prevention across the supply chain and stringent occupational health and safety measures to safeguard business continuity.